User profiles for Y. . Şenbabaoğlu
Yasin ŞenbabaoğluGenentech Verified email at gene.com Cited by 35800 |
TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
…, Y Yang, Y Guan, C Chalouni, J Ziai, Y Şenbabaoğlu… - Nature, 2018 - nature.com
Therapeutic antibodies that block the programmed death-1 (PD-1)–programmed death-ligand
1 (PD-L1) pathway can induce robust and durable responses in patients with various …
1 (PD-L1) pathway can induce robust and durable responses in patients with various …
[HTML][HTML] Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA …
… Coefficients are plotted on the y-axis in bar plots and asterisks are added to indicate level
of significance, as denoted in the legend. Tumor types are ordered in the same order as in Fig. …
of significance, as denoted in the legend. Tumor types are ordered in the same order as in Fig. …
[HTML][HTML] The head and neck cancer immune landscape and its immunotherapeutic implications
Recent clinical trials have demonstrated a clear survival advantage in advanced head and
neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade. …
neck squamous cell carcinoma (HNSCC) patients treated with immune checkpoint blockade. …
Mitochondrial DNA copy number variation across human cancers
10.7554/eLife.10769.001 Mutations, deletions, and changes in copy number of mitochondrial
DNA (mtDNA), are observed throughout cancers. Here, we survey mtDNA copy number …
DNA (mtDNA), are observed throughout cancers. Here, we survey mtDNA copy number …
[PDF][PDF] Multilevel genomics-based taxonomy of renal cell carcinoma
On the basis of multidimensional and comprehensive molecular characterization (including
DNA methalylation and copy number, RNA, and protein expression), we classified 894 renal …
DNA methalylation and copy number, RNA, and protein expression), we classified 894 renal …
[HTML][HTML] Pan-cancer analysis of intratumor heterogeneity as a prognostic determinant of survival
As tumors accumulate genetic alterations, an evolutionary process occurs in which
genetically distinct subclonal populations of cells co-exist, resulting in intratumor genetic …
genetically distinct subclonal populations of cells co-exist, resulting in intratumor genetic …
[PDF][PDF] Homeostatic functions of monocytes and interstitial lung macrophages are regulated via collagen domain-binding receptor LAIR1
S Keerthivasan, Y Şenbabaoğlu, N Martinez-Martin… - Immunity, 2021 - cell.com
Myeloid cells encounter stromal cells and their matrix determinants on a continual basis
during their residence in any given organ. Here, we examined the impact of the collagen …
during their residence in any given organ. Here, we examined the impact of the collagen …
[HTML][HTML] Tumor-intrinsic expression of the autophagy gene Atg16l1 suppresses anti-tumor immunity in colorectal cancer
L Taraborrelli, Y Şenbabaoğlu, L Wang, J Lim… - Nature …, 2023 - nature.com
Microsatellite-stable colorectal cancer (MSS-CRC) is highly refractory to immunotherapy.
Understanding tumor-intrinsic determinants of immunotherapy resistance is critical to improve …
Understanding tumor-intrinsic determinants of immunotherapy resistance is critical to improve …
[HTML][HTML] A multi-method approach for proteomic network inference in 11 human cancers
Y Şenbabaoğlu, SO Sümer… - PLoS computational …, 2016 - journals.plos.org
Protein expression and post-translational modification levels are tightly regulated in
neoplastic cells to maintain cellular processes known as ‘cancer hallmarks’. The first Pan-Cancer …
neoplastic cells to maintain cellular processes known as ‘cancer hallmarks’. The first Pan-Cancer …
[HTML][HTML] The neutrophil protein CD177 is a novel PDPN receptor that regulates human cancer-associated fibroblast physiology
…, S Keerthivasan, B Husain, Y Şenbabaoğlu… - PLoS …, 2021 - journals.plos.org
The cancer-associated fibroblast (CAF) marker podoplanin (PDPN) is generally correlated
with poor clinical outcomes in cancer patients and thus represents a promising therapeutic …
with poor clinical outcomes in cancer patients and thus represents a promising therapeutic …